注册 找回密码
搜索
查看: 481|回复: 0
打印 上一主题 下一主题

Sci:磷脂沉积药物无体内抗病毒活性难老药新用治SARS-CoV-2

[复制链接]
跳转到指定楼层
1#
发表于 2021-8-12 18:21:13 | 只看该作者 回帖奖励 |正序浏览 |阅读模式
本帖最后由 顾汉现 于 2021-8-12 18:37 编辑

药物诱导的磷脂沉积使多种药物难以“老药新用”于SARS-CoV-2

Sci:以磷脂沉积为机制的药物通常无体内抗病毒活性  难以老药新用于治SARS-CoV-2。
羟氯喹、阿奇霉素、胺碘酮 等都不行。

领研网

2021/08/08

论文
论文标题:Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2
作者:Tia A. Tummino , Veronica V. Rezelj , Benoit Fischer , Audrey Fischer , Matthew J. O’Meara , Blandine Monel , Thomas Vallet , Kris M. White , Ziyang Zhang , Assaf Alon , Heiko Schadt , Henry R. O’Donnell , Jiankun Lyu , Romel Rosales , Briana L. McGovern , Raveen Rathnasinghe , Sonia Jangra , Michael Schotsaert , Jean-René Galarneau , Nevan J. Krogan , Laszlo Urban , Kevan M. Shokat , Andrew C. Kruse , Adolfo García-Sastre , Olivier Schwartz , Francesca Moretti , Marco Vignuzzi , Francois Pognan , Brian K. Shoichet
查看更多
期刊:Science
发表时间:2021/07/30
数字识别码:10.1126/science.abi4708
摘要:Repurposing drugs as treatments for COVID-19, the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has drawn much attention. Beginning with sigma receptor ligands and expanding to other drugs from screening in the field, we became concerned that phospholipidosis was a shared mechanism underlying the antiviral activity of many repurposed drugs. For all of the 23 cationic amphiphilic drugs we tested, including hydroxychloroquine, azithromycin, amiodarone, and four others already in clinical trials, phospholipidosis was monotonically correlated with antiviral efficacy. Conversely, drugs active against the same targets that did not induce phospholipidosis were not antiviral. Phospholipidosis depends on the physicochemical properties of drugs and does not reflect specific target-based activities—rather, it may be considered a toxic confound in early drug discovery. Early detection of phospholipidosis could eliminate these artifacts, enabling a focus on molecules with therapeutic potential.
查看更多
所属学科:
药学
医学
(导读 郭怿暄)本研究发现在针对COVID-19的“老药新用”筛选中,许多药物在体外拥有抗病毒活性的原因是,它们能够引发磷脂沉积,例如,在本研究测试的23种阳离子两亲性药物中,磷脂沉积与抗病毒效力单调正相关。但是,此类以磷脂沉积为机制的药物通常没有体内抗病毒活性。因此,应当努力在早期发现此类药物,这有助于去除假象,筛选出真正有治疗潜能的分子。

https://science.sciencemag.org/content/373/6554/541

https://www.linkresearcher.com/t ... d-a4bc-c700defb1db5



华成旅行社  欢迎来电咨询:

电话:03-3833-9823  / 03-5688-1863
FAX :03-3833-9873  / 03-3834-5891

SOFTBANK电话:080-3416-2275   担当:小郭  微信号:08034162275
SOFTBANK电话:090-2172-4325   担当:小于  微信号:TYOSCL4325
SOFTBANK电话:080-3398-4387   担当:小李  微信号:huacheng4387
SOFTBANK电话:080-3523-4388   担当:小何  微信号:huacheng602
SOFTBANK电话:080-3084-4389   担当:小马  微信号:huacheng858

http://www.kaseisyoji.com/forum.php?mod=forumdisplay&fid=10

您需要登录后才可以回帖 登录 | 注册

本版积分规则

关于都市网 | 服务条款 | 开放平台 | 广告服务 | 商务洽谈 | 都市网招聘 | 都市网公益 | 客服中心 | 网站导航 | 版权所有

手机版|小黑屋|Comsenz Inc.  

© 2001-2013 源码论坛 Inc.    Powered by Weekend Design Discuz! X3.2

GMT+8, 2024-11-24 00:26 , Processed in 0.202398 second(s), 19 queries .

快速回复 返回顶部 返回列表